Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients.

We used TaqMan PCR to detect quantitative anomalies of tumor markers in both tumor and serum DNA from esophageal cancer patients. We demonstrated the potential of this methodology by detecting erbB-2 amplifications in a plurality of esophageal tumor samples. These amplifications were corroborated by Southern blots. We then showed the potential of this methodology to detect quantitative anomalies of erbB-2 in serum DNA from individuals with a corresponding amplification in the tumor. The capability of TaqMan PCR to detect abnormalities in serum of esophageal cancer patients creates an opportunity to diagnose esophageal cancer and to monitor the outcome of treatment with a blood test.

[1]  Thomas D. Schmittgen,et al.  Real-Time Quantitative PCR , 2002 .

[2]  I. Bièche,et al.  Novel approach to quantitative polymerase chain reaction using real‐time detection: Application to the detection of gene amplification in breast cancer , 1998, International journal of cancer.

[3]  K. Miller,et al.  Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. , 1998, Cancer research.

[4]  J. Jen,et al.  Molecular detection of genetic alterations in the serum of colorectal cancer patients. , 1998, Cancer research.

[5]  J. Cairns,et al.  A comparison between microsatellite and quantitative PCR analyses to detect frequent p16 copy number changes in primary bladder tumors. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  R. Rosell,et al.  Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  S. Gelmini,et al.  Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification. , 1997, Clinical chemistry.

[8]  D. Lashkari,et al.  Use of a fluorescent-PCR reaction to detect genomic sequence copy number and transcriptional abundance. , 1996, Genome research.

[9]  A. Kurt,et al.  Microsatellite alterations in plasma DNA of small cell lung cancer patients , 1996, Nature Medicine.

[10]  David Sidransky,et al.  Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.

[11]  Y. Konda,et al.  Molecular cloning of a novel receptor (CMKLR1) with homology to the chemotactic factor receptors. , 1996, Cytogenetics and cell genetics.

[12]  K. Livak,et al.  Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. , 1995, PCR methods and applications.

[13]  A. Raap,et al.  FISH in genome research and molecular diagnostics. , 1995, Current opinion in genetics & development.

[14]  C. Disteche,et al.  Down syndrome phenotypes: the consequences of chromosomal imbalance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Antonarakis,et al.  Determination of gene dosage by a quantitative adaptation of the polymerase chain reaction (gd-PCR): rapid detection of deletions and duplications of gene sequences. , 1994, Genomics.

[16]  S Nedjar,et al.  Simultaneous amplification and detection of specific hepatitis B virus and hepatitis C virus genomic sequences in serum samples , 1994, Journal of medical virology.

[17]  D. Beer,et al.  Amplification and over‐expression of the EGFR and erbB‐2 genes in human esophageal adenocarcinomas , 1993, International journal of cancer.

[18]  G. Buchman,et al.  Uracil DNA glycosylase-mediated cloning of polymerase chain reaction-amplified DNA: application to genomic and cDNA cloning. , 1992, Analytical biochemistry.

[19]  P. Walsh,et al.  Simultaneous Amplification and Detection of Specific DNA Sequences , 1992, Bio/Technology.

[20]  J. Elashoff,et al.  Precise gene dosage determination by polymerase chain reaction: theory, methodology, and statistical approach. , 1991, Molecular and cellular probes.

[21]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[22]  W. Cavenee,et al.  Loss of constitutional heterozygosity in human cancer. , 1991, Annual review of genetics.

[23]  M. Stroun,et al.  Isolation and characterization of DNA from the plasma of cancer patients. , 1987, European journal of cancer & clinical oncology.

[24]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[25]  U. Schibler,et al.  Changes in size and secondary structure of the ribosomal transcription unit during vertebrate evolution. , 1975, Journal of molecular biology.